Sangamo Therapeutics Inc (SGMO)

Sangamo Therapeutics Inc (SGMO) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	76.44% 0.481	2.042	9.398	6.835	157.96
Operating Expenses	18.87% 52.01	64.10	115.81	130.41	139.92
Benefits Costs and Expenses	20.98% 49.47	62.61	112.29	127.61	136.63
Costs And Expenses	20.98% 49.47	62.61	112.29	127.61	136.63
Operating Income/Loss	16.97% -51.53	-62.06	-106.41	-123.57	18.03
Income/Loss From Continuing Operations Before Tax	19.11% -48.99	-60.57	-102.89	-120.77	21.33
Income Tax Expense/Benefit	136.03% 0.098	-0.272	1.27	-6.264	0.194
Income/Loss From Continuing Operations After Tax	18.59% -49.09	-60.30	-104.16	-114.51	21.13
Net Income/Loss	18.59% -49.09	-60.30	-104.16	-114.51	21.13
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	16,770% 180.34	1.069	177.17	174.32	168.53
Diluted Average Shares	16,770% 180.34	1.069	177.17	174.32	169.18
Basic Earnings Per Share	20.59% -0.27	-0.34	-0.59	-0.66	0.13
Diluted Earnings Per Share	20.59% -0.27	-0.34	-0.59	-0.66	0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-